Induced Pluripotent Stem Cells Production Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Induced Pluripotent Stem Cells Market is Segmented by Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Neurons and Others), Application (Drug Development, Regenerative Medicine, Toxicity Testing, Tissue Engineering and Cell Therapy), End User (Research Institutions and Other End Users) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The Market Provides the Value (in USD) for the Above-Mentioned Segments.

Induced Pluripotent Stem Cells Production Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Induced Pluripotent Stem Cells (iPSCs) Industry Overview

The induced pluripotent stem cells market is competitive and consists of several key players. The companies are focusing on adopting various key strategies such as mergers, collaborations, acquisitions, partnerships, and product launches to withhold their position in the market. Some of the companies in the market are Axol Bioscience Ltd., Cynata Therapeutics Limited, Evotec SE, FUJIFILM Cellular Dynamics, Inc., Ncardia, Pluricell Biotech, and REPROCELL USA, Inc. among others. 

Induced Pluripotent Stem Cells (iPSCs) Market Leaders

  1. Axol Bioscience Ltd.

  2. Cynata Therapeutics Limited

  3. Evotec SE

  4. FUJIFILM Cellular Dynamics, Inc.

  5. Ncardia

  6. *Disclaimer: Major Players sorted in no particular order
Induced Pluripotent Stem Cells Market Concentration

Induced Pluripotent Stem Cell (IPSC) Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?